Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Melissa Magliocco"'
Publikováno v:
Journal of drugs in dermatology : JDD. 5(9)
Infliximab demonstrates high efficacy in treating psoriasis in a high proportion of patients. In this report we demonstrate induction of plaque (T cells, dendritic cells) and peripheral blood (T cells, monocytes) leukocyte apoptosis following a singl
Autor:
Alice B. Gottlieb, Andrew C. Wang, Rama Malaviya, Melissa Yao, Jennifer K. Tan, Yvonne Sun, James G. Krueger, Melissa Magliocco
Publikováno v:
Journal of the American Academy of Dermatology. 55(4)
Background Etanercept is a tumor necrosis factor-α binding fusion protein that demonstrates efficacy in the treatment of psoriasis, which is accompanied by decreased plaque infiltration of T cells and myeloid dendritic cells. We hypothesized that et
Autor:
Melissa Magliocco, Francesca Chamian, James G. Krueger, Alice B. Gottlieb, Maria Veronica Abello, Irma Cardinale, Michelle A. Lowes, Fei Chen, Salman Masud
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 175(4)
The mechanisms of action of marketed TNF-blocking drugs in lesional tissues are still incompletely understood. Because psoriasis plaques are accessible to repeat biopsy, the effect of TNF/lymphotoxin blockade with etanercept (soluble TNFR) was studie
Autor:
Viktor Y. Dombrovskiy, Komal M Pandya, Yuk Wong, Linda Christiansen, Melissa Magliocco, Alice B. Gottlieb
Publikováno v:
Journal of the American Academy of Dermatology. 54(1)
We report results of a randomized, vehicle-controlled, bilateral comparison pilot study of bexarotene gel 1% with narrowband UVB (NBUVB) phototherapy for moderate to severe psoriasis. In all, 9 patients applied drug or vehicle gel to comparable targe
Autor:
Alice B. Gottlieb, Melissa Magliocco
Publikováno v:
Journal of the American Academy of Dermatology. 51(4)
Psoriasis and psoriatic arthritis are exacerbated by interferon alfa and other treatments for hepatitis C virus infection. Immunosuppressants and hepatotoxic drugs are relatively contraindicated in hepatitis C. Data in the literature suggest that eta
Investigator-Initiated Trial of Efalizumab for Atopic Dermatitis: A Proof-of-Concept Study in Adults
Publikováno v:
Clinical Immunology. 123:S166
Publikováno v:
Journal of the American Academy of Dermatology. 50:P122